Senescent Cells: A Therapeutic Target in Cardiovascular Diseases
Open accessThe DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Abstract
Senescent cell accumulation has been observed in age-associated diseases including cardiovascular diseases. Senescent cells lack proliferative capacity and secrete senescence-associated secretory phenotype (SASP) factors that may cause or worsen many cardiovascular diseases. Therapies targeting senescent cells, especially senolytic drugs that selectively induce senescent cell removal, have been shown to delay, prevent, alleviate, or treat multiple age-associated diseases in preclinical models. Some senolytic clinical trials have already been completed or are underway for a number of diseases and geriatric syndromes. Understanding how cellular senescence affects the various cell types in the cardiovascular system, such as endothelial cells, vascular smooth muscle cells, fibroblasts, immune cells, progenitor cells, and cardiomyocytes, is important to facilitate translation of senotherapeutics into clinical interventions. This review highlights: (1) the characteristics of senescent cells and their involvement in cardiovascular diseases, focusing on the aforementioned cardiovascular cell types, (2) evidence about senolytic drugs and other senotherapeutics, and (3) the future path and clinical potential of senotherapeutics for cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“For example, metformin, an established anti-diabetes medication, improves cardiovascular diseases [244] and cognitive dysfunction [245], attenuates cancer formation and resistance [246,247], and might increase lifespan [248].”
BackgroundLópez-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · cited 1×
“Many or most of these syndromes might be alleviated by targeting the hallmarks of aging [201].”
BackgroundThe serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508 · cited 1×
“Human cells have limited replicative potential, as discovered by Hayflick and Moorehead in 1961 [38].”
BackgroundHeart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358 · cited 1×
“Senescent-like T cells with the CD8+CD57+CD27−CD28null phenotype produce large amounts of IFN-γ and TNF-α and may promote inflammation in atherosclerotic disease [167].”
BackgroundCellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“, INK-ATTAC mice, from which highly p16Ink4a-expressing cells can be targeted for apoptosis using an agent, AP20187, that does not target cells without high expression of p16Ink4a [207].”
BackgroundSelf-citationCirculating endothelial progenitor cells, vascular function, and cardiovascular risk
Hill, J. M., Zalos, G., Halcox, J. P. J., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A., & Finkel, T. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022287 · Cited by 3,423
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 1×
“There are currently no highly sensitive and specific individual markers for senescent cardiovascular cells in vivo [68].”
BackgroundEvidence for Cardiomyocyte Renewal in Humans
Bergmann, O., Bhardwaj, R. D., Bernard, S., Zdunek, S., Barnabé-Heider, F., Walsh, S., Zupicich, J., Alkass, K., Buchholz, B. A., Druid, H., et al. (2009) · Science · doi:10.1126/science.1164680 · Cited by 3,130
The effect of digoxin on mortality and morbidity in patients with heart failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 29×
“In atherosclerotic diseases, senescent ECs, VSMCs, fibroblasts, and inflammatory cells cause or worsen plaque buildup and destabilize existing plaques.”
BackgroundMethodInfluentialSelf-citationSenolytics improve physical function and increase lifespan in old age
Xu, M., Pirtskhalava, T., Farr, J. N., Weigand, B. M., Palmer, A. K., Weivoda, M. M., Inman, C. L., Ogrodnik, M. B., Hachfeld, C. M., Fraser, D. G., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0092-9 · Cited by 2,287 · cited 2×
“Additionally, intermittently eliminating senescent cells alleviated physical dysfunction after senescent cell transplantation, all pointing toward a causal role of senescent cells in aging phenotypes and diseases [208].”
BackgroundSelf-citationCellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
Ageing as a Risk Factor for Disease
Niccoli, T., & Partridge, L. (2012) · Current Biology · doi:10.1016/j.cub.2012.07.024 · Cited by 1,831
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819 · cited 1×
“Based on the BCL-xL siRNA studies in the first article about senolytics, two groups subsequently found that the BCL-xL/BCL2/BCL-w inhibitor, navitoclax (ABT263), also exhibits senolytic activity [210,211].”
BackgroundCellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., & Kirkland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64098 · Cited by 1,774 · cited 1×
“Examples of such SASP factors include interleukin-1α (IL-1α), IL-6, interleukin-8 (IL-8), IL-17, plasminogen activator inhibitors 1 and 2 (PAI-1, PAI-2), and profibrotic metalloproteases such as MMP-2, MMP-9, and MMP-12 [48].”
BackgroundSelf-citationCellular senescence mediates fibrotic pulmonary disease
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14532 · Cited by 1,613 · cited 2×
“In vitro, senescent fibroblasts can secrete profibrotic enzymes [23].”
BackgroundSelf-citationThe intersection between aging and cardiovascular disease
North, B. J., & Sinclair, D. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.246876 · Cited by 1,585
Ink4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486
Baar, M. P., Brandt, R. M. C., Putavet, D. A., Klein, J. D. D., Derks, K. W. J., Bourgeois, B. R. M., Stryeck, S., Rijksen, Y., van Willigenburg, H., Feijtel, D. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.031 · Cited by 1,454
Hickson, L. J., Langhi Prata, L. G. P., Bobart, S. A., Evans, T. K., Giorgadze, N., Hashmi, S. K., Herrmann, S. M., Jensen, M. D., Jia, Q., Jordan, K. L., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.069 · Cited by 1,383 · cited 1×
“Among the first such blood composite score indicative of senescent cell burden and effect of senolytic drugs was examined in a study of senolytics administered to obese young adults with diabetes [71].”
BackgroundSelf-citationA proteomic atlas of senescence-associated secretomes for aging biomarker development
Basisty, N., Kale, A., Jeon, O. H., Kuehnemann, C., Payne, T., Rao, C., Holtz, A., Shah, S., Sharma, V., Ferrucci, L., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000599 · Cited by 1,348
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Justice, J. N., Nambiar, A. M., Tchkonia, T., LeBrasseur, N. K., Pascual, R., Hashmi, S. K., Prata, L., Masternak, M. M., Kritchevsky, S. B., Musi, N., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.052 · Cited by 1,261 · cited 2×
“The first clinical trial in which the benefit of senolytics was reported in humans was in patients with idiopathic pulmonary fibrosis (IPF) [258].”
BackgroundSelf-citationTargeting cellular senescence prevents age-related bone loss in mice
Farr, J. N., Xu, M., Weivoda, M. M., Monroe, D. G., Fraser, D. G., Onken, J. L., Negley, B. A., Sfeir, J. G., Ogrodnik, M. B., Hachfeld, C. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4385 · Cited by 1,182
Self-citationLaberge, R.-M., Sun, Y., Orjalo, A. V., Patil, C. K., Freund, A., Zhou, L., Curran, S. C., Davalos, A. R., Wilson-Edell, K. A., Liu, S., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3195 · Cited by 1,160 · cited 1×
“For example, metformin, an established anti-diabetes medication, improves cardiovascular diseases [244] and cognitive dysfunction [245], attenuates cancer formation and resistance [246,247], and might increase lifespan [248].”
BackgroundZhu, Y., Tchkonia, T., Fuhrmann‐Stroissnigg, H., Dai, H. M., Ling, Y. Y., Stout, M. B., Pirtskhalava, T., Giorgadze, N., Johnson, K. O., Giles, C. B., et al. (2016) · Aging Cell · doi:10.1111/acel.12445 · Cited by 1,148 · cited 1×
“Based on the BCL-xL siRNA studies in the first article about senolytics, two groups subsequently found that the BCL-xL/BCL2/BCL-w inhibitor, navitoclax (ABT263), also exhibits senolytic activity [210,211].”
BackgroundSelf-citationCellular senescence and senolytics: the path to the clinic
Chaib, S., Tchkonia, T., & Kirkland, J. L. (2022) · Nature Medicine · doi:10.1038/s41591-022-01923-y · Cited by 1,134 · cited 5×
“Furthermore, since cellular senescence and other underlying causes of these age-associated chronic diseases (the hallmarks of aging) are interlinked with each other, intervening against any one of them may affect most or all of the other aging processes, as expressed in “The Unitary Theory of Fundamental Aging Mechani…”
BackgroundInfluentialSelf-citationSenolytic CAR T cells reverse senescence-associated pathologies
Amor, C., Feucht, J., Leibold, J., Ho, Y.-J., Zhu, C., Alonso-Curbelo, D., Mansilla-Soto, J., Boyer, J. A., Li, X., Giavridis, T., et al. (2020) · Nature · doi:10.1038/s41586-020-2403-9 · Cited by 1,098 · cited 2×
“uPAR-specific CAR-T cells aggregated around uPAR-positive senescent cells and eliminated them, alleviating non-alcoholic steatohepatitis and drug-induced liver fibrosis in mouse models [225].”
BackgroundMetformin as a tool to target aging
Barzilai, N., Crandall, J. P., Kritchevsky, S. B., & Espeland, M. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.011 · Cited by 1,096 · cited 1×
“For example, metformin, an established anti-diabetes medication, improves cardiovascular diseases [244] and cognitive dysfunction [245], attenuates cancer formation and resistance [246,247], and might increase lifespan [248].”
BackgroundFat tissue, aging, and cellular senescence
Tchkonia, T., Morbeck, D. E., Von Zglinicki, T., Van Deursen, J., Lustgarten, J., Scrable, H., Khosla, S., Jensen, M. D., & Kirkland, J. L. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00608.x · Cited by 1,094
Self-citationEndothelial Cell Senescence in Human Atherosclerosis: Role of Telomere in Endothelial Dysfunction
Minamino, T., Miyauchi, H., Yoshida, T., Ishida, Y., Yoshida, H., & Komuro, I. (2002) · Circulation · doi:10.1161/01.cir.0000013836.85741.17 · Cited by 1,061
Self-citationCellular senescence drives age-dependent hepatic steatosis
Ogrodnik, M., Miwa, S., Tchkonia, T., Tiniakos, D., Wilson, C. L., Lahat, A., Day, C. P., Burt, A., Palmer, A., Anstee, Q. M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15691 · Cited by 1,044
Self-citationFreund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039 · cited 1×
“Markers that can be expressed by senescent cells include the cell cycle arrest proteins p53/p21CIP1/WAF1 and p16INK4a/Rb, DNA damage-related factors such as gamma-H2AX (γ-H2AX), p38 mitogen-activated protein kinase (p38MAPK) activity [52,53], telomereassociated foci (TAFs) [54,55], and senescence-associated β-galactos…”
BackgroundSpilman, P., Podlutskaya, N., Hart, M. J., Debnath, J., Gorostiza, O., Bredesen, D., Richardson, A., Strong, R., & Galvan, V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009979 · Cited by 1,033
Fisetin is a senotherapeutic that extends health and lifespan
Yousefzadeh, M. J., Zhu, Y., McGowan, S. J., Angelini, L., Fuhrmann-Stroissnigg, H., Xu, M., Ling, Y. Y., Melos, K. I., Pirtskhalava, T., Inman, C. L., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.015 · Cited by 1,032
Self-citationA new gene set identifies senescent cells and predicts senescence-associated pathways across tissues
Saul, D., Kosinsky, R. L., Atkinson, E. J., Doolittle, M. L., Zhang, X., LeBrasseur, N. K., Pignolo, R. J., Robbins, P. D., Niedernhofer, L. J., Ikeno, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32552-1 · Cited by 1,022 · cited 1×
“This yields a senescence score that was reduced in bone samples after genetic clearance of senescent cells in mice as well as in human adipose tissue following pharmacological senescent cell clearance [72].”
BackgroundSelf-citationFeedback between p21 and reactive oxygen production is necessary for cell senescence
Passos, J. F., Nelson, G., Wang, C., Richter, T., Simillion, C., Proctor, C. J., Miwa, S., Olijslagers, S., Hallinan, J., Wipat, A., et al. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.5 · Cited by 1,019
Cellular senescence: a translational perspective
Kirkland, J. L., & Tchkonia, T. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.013 · Cited by 1,013
Self-citationMacrophages Facilitate Electrical Conduction in the Heart
Hulsmans, M., Clauss, S., Xiao, L., Aguirre, A. D., King, K. R., Hanley, A., Hucker, W. J., Wülfers, E. M., Seemann, G., Courties, G., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.050 · Cited by 1,011 · cited 1×
“These findings elucidate the role of macrophages in normal and aberrant cardiac conduction [157].”
BackgroundIn Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
Ocampo, A., Reddy, P., Martinez-Redondo, P., Platero-Luengo, A., Hatanaka, F., Hishida, T., Li, M., Lam, D., Kurita, M., Beyret, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.052 · Cited by 988
Unmasking Transcriptional Heterogeneity in Senescent Cells
Hernandez-Segura, A., de Jong, T. V., Melov, S., Guryev, V., Campisi, J., & Demaria, M. (2017) · Current Biology · doi:10.1016/j.cub.2017.07.033 · Cited by 972
Xu, M., Tchkonia, T., Ding, H., Ogrodnik, M., Lubbers, E. R., Pirtskhalava, T., White, T. A., Johnson, K. O., Stout, M. B., Mezera, V., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515386112 · Cited by 915 · cited 8×
“Senescent endothelial cells exhibit increased production of ROS and certain SASP markers, such as intercellular adhesion molecule-1 (ICAM-1) [102,103], IL-1 [104], IL-6 [105], IL-8 [106], and MCP-1 [106], facilitating immune cell infiltration of tissues.”
BackgroundInfluentialSelf-citationHewitt, G., Jurk, D., Marques, F. D. M., Correia-Melo, C., Hardy, T., Gackowska, A., Anderson, R., Taschuk, M., Mann, J., & Passos, J. F. (2012) · Nature Communications · doi:10.1038/ncomms1708 · Cited by 908 · cited 1×
“Markers that can be expressed by senescent cells include the cell cycle arrest proteins p53/p21CIP1/WAF1 and p16INK4a/Rb, DNA damage-related factors such as gamma-H2AX (γ-H2AX), p38 mitogen-activated protein kinase (p38MAPK) activity [52,53], telomereassociated foci (TAFs) [54,55], and senescence-associated β-galactos…”
BackgroundLoss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
Sharpless, N. E., Bardeesy, N., Lee, K.-H., Carrasco, D., Castrillon, D. H., Aguirre, A. J., Wu, E. A., Horner, J. W., & DePinho, R. A. (2001) · Nature · doi:10.1038/35092592 · Cited by 848
Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence
Passos, J. F., Saretzki, G., Ahmed, S., Nelson, G., Richter, T., Peters, H., Wappler, I., Birket, M. J., Harold, G., Schaeuble, K., et al. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050110 · Cited by 796
Microarray analysis of replicative senescence
Shelton, D. N., Chang, E., Whittier, P. S., Choi, D., & Funk, W. D. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80420-5 · Cited by 764
A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart
Nicolás-Ávila, J. A., Lechuga-Vieco, A. V., Esteban-Martínez, L., Sánchez-Díaz, M., Díaz-García, E., Santiago, D. J., Rubio-Ponce, A., Li, J. L., Balachander, A., Quintana, J. A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.031 · Cited by 762
Zhu, Y., Doornebal, E. J., Pirtskhalava, T., Giorgadze, N., Wentworth, M., Fuhrmann-Stroissnigg, H., Niedernhofer, L. J., Robbins, P. D., Tchkonia, T., & Kirkland, J. L. (2017) · Aging · doi:10.18632/aging.101202 · Cited by 757
Self-citationRoos, C. M., Zhang, B., Palmer, A. K., Ogrodnik, M. B., Pirtskhalava, T., Thalji, N. M., Hagler, M., Jurk, D., Smith, L. A., Casaclang‐Verzosa, G., et al. (2016) · Aging Cell · doi:10.1111/acel.12458 · Cited by 738
Self-citationTargeting senescent cells alleviates obesity-induced metabolic dysfunction
Palmer, A. K., Xu, M., Zhu, Y., Pirtskhalava, T., Weivoda, M. M., Hachfeld, C. M., Prata, L. G., van Dijk, T. H., Verkade, E., Casaclang‐Verzosa, G., et al. (2019) · Aging Cell · doi:10.1111/acel.12950 · Cited by 658
Self-citationMoiseeva, O., Deschênes‐Simard, X., St‐Germain, E., Igelmann, S., Huot, G., Cadar, A. E., Bourdeau, V., Pollak, M. N., & Ferbeyre, G. (2013) · Aging Cell · doi:10.1111/acel.12075 · Cited by 654
A guide to assessing cellular senescence in vitro and in vivo
González‐Gualda, E., Baker, A. G., Fruk, L., & Muñoz‐Espín, D. (2021) · The FEBS Journal · doi:10.1111/febs.15570 · Cited by 645
Loss of epigenetic information as a cause of mammalian aging
Yang, J.-H., Hayano, M., Griffin, P. T., Amorim, J. A., Bonkowski, M. S., Apostolides, J. K., Salfati, E. L., Blanchette, M., Munding, E. M., Bhakta, M., et al. (2023) · Cell · doi:10.1016/j.cell.2022.12.027 · Cited by 643
Matthews, C., Gorenne, I., Scott, S., Figg, N., Kirkpatrick, P., Ritchie, A., Goddard, M., & Bennett, M. (2006) · Circulation Research · doi:10.1161/01.res.0000233315.38086.bc · Cited by 615 · cited 9×
“They are both tied to senescent cell accumulation, evidenced by high numbers of SA-ßgal, p53, and p21 CIP1/WAF1 positive cells in patients with thoracic aortic aneurysms and dissections.”
BackgroundInfluentialVascular smooth muscle cell death, autophagy and senescence in atherosclerosis
Grootaert, M. O. J., Moulis, M., Roth, L., Martinet, W., Vindis, C., Bennett, M. R., & De Meyer, G. R. Y. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy007 · Cited by 606
Targeting senescent cells enhances adipogenesis and metabolic function in old age
Xu, M., Palmer, A. K., Ding, H., Weivoda, M. M., Pirtskhalava, T., White, T. A., Sepe, A., Johnson, K. O., Stout, M. B., Giorgadze, N., et al. (2015) · eLife · doi:10.7554/elife.12997 · Cited by 604 · cited 1×
“host disease) [106] alleviated age-related adipose tissue dysfunction [15] and frailty [254].”
BackgroundSelf-citationTissue damage and senescence provide critical signals for cellular reprogramming in vivo
Mosteiro, L., Pantoja, C., Alcazar, N., Marión, R. M., Chondronasiou, D., Rovira, M., Fernandez-Marcos, P. J., Muñoz-Martin, M., Blanco-Aparicio, C., Pastor, J., et al. (2016) · Science · doi:10.1126/science.aaf4445 · Cited by 589
Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome
Liu, G.-H., Barkho, B. Z., Ruiz, S., Diep, D., Qu, J., Yang, S.-L., Panopoulos, A. D., Suzuki, K., Kurian, L., Walsh, C., et al. (2011) · Nature · doi:10.1038/nature09879 · Cited by 575
Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state
Lapasset, L., Milhavet, O., Prieur, A., Besnard, E., Babled, A., Aït-Hamou, N., Leschik, J., Pellestor, F., Ramirez, J.-M., De Vos, J., et al. (2011) · Genes & Development · doi:10.1101/gad.173922.111 · Cited by 570
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A., & Berns, A. (2001) · Nature · doi:10.1038/35092584 · Cited by 568
Reprogramming in vivo produces teratomas and iPS cells with totipotency features
Abad, M., Mosteiro, L., Pantoja, C., Cañamero, M., Rayon, T., Ors, I., Graña, O., Megías, D., Domínguez, O., Martínez, D., et al. (2013) · Nature · doi:10.1038/nature12586 · Cited by 547
Vascular Cell Senescence: Contribution to Atherosclerosis
Minamino, T., & Komuro, I. (2007) · Circulation Research · doi:10.1161/01.res.0000256837.40544.4a · Cited by 542
Self-citationObesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis
Ogrodnik, M., Zhu, Y., Langhi, L. G. P., Tchkonia, T., Krüger, P., Fielder, E., Victorelli, S., Ruswhandi, R. A., Giorgadze, N., Pirtskhalava, T., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.008 · Cited by 536
Self-citationLength-independent telomere damage drives post-mitotic cardiomyocyte senescence
Anderson, R., Lagnado, A., Maggiorani, D., Walaszczyk, A., Dookun, E., Chapman, J., Birch, J., Salmonowicz, H., Ogrodnik, M., Jurk, D., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100492 · Cited by 532 · cited 8×
“INK-ATTAC Navitoclax Alleviated myocardial hypertrophy and fibrosis [54]”
BackgroundInfluentialSelf-citationExpression of p16 INK4a in peripheral blood T‐cells is a biomarker of human aging
Liu, Y., Sanoff, H. K., Cho, H., Burd, C. E., Torrice, C., Ibrahim, J. G., Thomas, N. E., & Sharpless, N. E. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00489.x · Cited by 509
Platonov, P. G., Mitrofanova, L. B., Orshanskaya, V., & Ho, S. Y. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.061 · Cited by 496 · cited 1×
“In atrial fibrillation (AF), the most common arrhythmia worldwide affecting aged individuals, pathological fibrosis is theorized to disrupt electrical conductance through cardiomyocyte gap junctions in the atrium [263,264].”
BackgroundOhnishi, K., Semi, K., Yamamoto, T., Shimizu, M., Tanaka, A., Mitsunaga, K., Okita, K., Osafune, K., Arioka, Y., Maeda, T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.005 · Cited by 460
Defined p16High Senescent Cell Types Are Indispensable for Mouse Healthspan
Grosse, L., Wagner, N., Emelyanov, A., Molina, C., Lacas-Gervais, S., Wagner, K.-D., & Bulavin, D. V. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.05.002 · Cited by 460
Endothelial cell senescence in aging-related vascular dysfunction
Jia, G., Aroor, A. R., Jia, C., & Sowers, J. R. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.008 · Cited by 454 · cited 1×
“Cellular senescence caused by macromolecular damage, inflammation, deregulated nutrient sensing, and telomere modification is associated with systolic hypertension [293,294].”
BackgroundHall, B. M., Balan, V., Gleiberman, A. S., Strom, E., Krasnov, P., Virtuoso, L. P., Rydkina, E., Vujcic, S., Balan, K., Gitlin, I. I., et al. (2017) · Aging · doi:10.18632/aging.101268 · Cited by 407 · cited 1×
“A recent study demonstrated that macrophages are the most common p16Ink4a/SAβgal-positive cells accumulating in aging mice [159].”
BackgroundOgrodnik, M., Evans, S. A., Fielder, E., Victorelli, S., Kruger, P., Salmonowicz, H., Weigand, B. M., Patel, A. D., Pirtskhalava, T., Inman, C. L., et al. (2021) · Aging Cell · doi:10.1111/acel.13296 · Cited by 405 · cited 1×
“Accumulating in vivo and in vitro evidence indicates that cellular senescence contributes to chronic disorders such as cardiovascular diseases [5–8], type 2 diabetes and other age-related metabolic conditions [9–17], liver disease in association with hyperinsulinemia, metabolic syndrome, age-dependent steatosis [18–20…”
BackgroundSelf-citationQuantitative identification of senescent cells in aging and disease
Biran, A., Zada, L., Abou Karam, P., Vadai, E., Roitman, L., Ovadya, Y., Porat, Z., & Krizhanovsky, V. (2017) · Aging Cell · doi:10.1111/acel.12592 · Cited by 402
Cellular senescence, cancer and aging: the telomere connection
Campisi, J., Kim, S.-H., Lim, C.-S., & Rubio, M. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00160-7 · Cited by 400
Identification and characterization of Cardiac Glycosides as senolytic compounds
Triana-Martínez, F., Picallos-Rabina, P., Da Silva-Álvarez, S., Pietrocola, F., Llanos, S., Rodilla, V., Soprano, E., Pedrosa, P., Ferreirós, A., Barradas, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12888-x · Cited by 384
How ageing processes influence cancer
de Magalhães, J. P. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3497 · Cited by 367
Cardiac glycosides are broad-spectrum senolytics
Guerrero, A., Herranz, N., Sun, B., Wagner, V., Gallage, S., Guiho, R., Wolter, K., Pombo, J., Irvine, E. E., Innes, A. J., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0122-z · Cited by 359 · cited 2×
“Senolytics such as navitoclax [162,279], anti-GPNMB vaccination [222], digoxin [217,218,280], BPTES [220], and 17-DMAG (alvespimycin) [281], reduce atherosclerotic plaque formation and inflammation in atherosclerotic model mice.”
BackgroundJustice, J. N., Ferrucci, L., Newman, A. B., Aroda, V. R., Bahnson, J. L., Divers, J., Espeland, M. A., Marcovina, S., Pollak, M. N., Kritchevsky, S. B., et al. (2018) · GeroScience · doi:10.1007/s11357-018-0042-y · Cited by 359
Bannister, C. A., Holden, S. E., Jenkins‐Jones, S., Morgan, C. L., Halcox, J. P., Schernthaner, G., Mukherjee, J., & Currie, C. J. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12354 · Cited by 356 · cited 1×
“For example, metformin, an established anti-diabetes medication, improves cardiovascular diseases [244] and cognitive dysfunction [245], attenuates cancer formation and resistance [246,247], and might increase lifespan [248].”
BackgroundVascular Smooth Muscle Cell Senescence Promotes Atherosclerosis and Features of Plaque Vulnerability
Wang, J., Uryga, A. K., Reinhold, J., Figg, N., Baker, L., Finigan, A., Gray, K., Kumar, S., Clarke, M., & Bennett, M. (2015) · Circulation · doi:10.1161/circulationaha.115.016457 · Cited by 349
Ramos, F. J., Chen, S. C., Garelick, M. G., Dai, D.-F., Liao, C.-Y., Schreiber, K. H., MacKay, V. L., An, E. H., Strong, R., Ladiges, W. C., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003802 · Cited by 349 · cited 1×
“Rapamycin, used clinically as an immunosuppressant, improved heart failure [249], cognitive decline [250], immune dysfunction [251], frailty [252], and possibly lifespan [253].”
BackgroundThe flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice
Xu, Q., Fu, Q., Li, Z., Liu, H., Wang, Y., Lin, X., He, R., Zhang, X., Ju, Z., Campisi, J., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00491-8 · Cited by 341
Self-citationTissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice
Yousefzadeh, M. J., Zhao, J., Bukata, C., Wade, E. A., McGowan, S. J., Angelini, L. A., Bank, M. P., Gurkar, A. U., McGuckian, C. A., Calubag, M. F., et al. (2020) · Aging Cell · doi:10.1111/acel.13094 · Cited by 331 · cited 1×
“Consequently, senescent cell burden is high in well-vascularized tissues with many endothelial cells [84].”
BackgroundSenolytics reduce coronavirus-related mortality in old mice
Camell, C. D., Yousefzadeh, M. J., Zhu, Y., Prata, L. G. P. L., Huggins, M. A., Pierson, M., Zhang, L., O’Kelly, R. D., Pirtskhalava, T., Xun, P., et al. (2021) · Science · doi:10.1126/science.abe4832 · Cited by 320 · cited 1×
“Advanced biological age is also associated with loss of physical resilience, such as against infection [199,200], injury, or surgery or dampened vaccination responses.”
BackgroundSelf-citationAged-senescent cells contribute to impaired heart regeneration
Lewis‐McDougall, F. C., Ruchaya, P. J., Domenjo‐Vila, E., Shin Teoh, T., Prata, L., Cottle, B. J., Clark, J. E., Punjabi, P. P., Awad, W., Torella, D., et al. (2019) · Aging Cell · doi:10.1111/acel.12931 · Cited by 317
Self-citationCoppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302
Identification of an atypical monocyte and committed progenitor involved in fibrosis
Satoh, T., Nakagawa, K., Sugihara, F., Kuwahara, R., Ashihara, M., Yamane, F., Minowa, Y., Fukushima, K., Ebina, I., Yoshioka, Y., et al. (2017) · Nature · doi:10.1038/nature20611 · Cited by 302
Suda, M., Shimizu, I., Katsuumi, G., Yoshida, Y., Hayashi, Y., Ikegami, R., Matsumoto, N., Yoshida, Y., Mikawa, R., Katayama, A., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00151-2 · Cited by 290 · cited 2×
“This vaccine also improved physical function in aged mice and increased lifespan in progeroid mice [223].”
BackgroundSelf-citationDNA damage response and metabolic disease
Shimizu, I., Yoshida, Y., Suda, M., & Minamino, T. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.008 · Cited by 286
Self-citationDiscovery of piperlongumine as a potential novel lead for the development of senolytic agents
Wang, Y., Chang, J., Liu, X., Zhang, X., Zhang, S., Zhang, X., Zhou, D., & Zheng, G. (2016) · Aging · doi:10.18632/aging.101100 · Cited by 274
Browder, K. C., Reddy, P., Yamamoto, M., Haghani, A., Guillen, I. G., Sahu, S., Wang, C., Luque, Y., Prieto, J., Shi, L., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00183-2 · Cited by 253
Walaszczyk, A., Dookun, E., Redgrave, R., Tual‐Chalot, S., Victorelli, S., Spyridopoulos, I., Owens, A., Arthur, H. M., Passos, J. F., & Richardson, G. D. (2019) · Aging Cell · doi:10.1111/acel.12945 · Cited by 250 · cited 2×
“In mouse and rat models of ischemia reperfusion, navitoclax appeared to alleviate myocardial fibrosis and hypertrophy [270,271] and improved left ventricular ejection fraction with increased survival in aged mice [54,272,273].”
BackgroundEssential role for premature senescence of myofibroblasts in myocardial fibrosis
Meyer, K., Hodwin, B., Ramanujam, D., Engelhardt, S., & Sarikas, A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.02.047 · Cited by 247 · cited 2×
“These senescent cells accumulated within fibrotic areas [188].”
BackgroundWiley, C. D., Flynn, J. M., Morrissey, C., Lebofsky, R., Shuga, J., Dong, X., Unger, M. A., Vijg, J., Melov, S., & Campisi, J. (2017) · Aging Cell · doi:10.1111/acel.12632 · Cited by 234
Loo, T. M., Miyata, K., Tanaka, Y., & Takahashi, A. (2020) · Cancer Science · doi:10.1111/cas.14266 · Cited by 232
Disturbed Flow Promotes Endothelial Senescence via a p53-Dependent Pathway
Warboys, C. M., de Luca, A., Amini, N., Luong, L., Duckles, H., Hsiao, S., White, A., Biswas, S., Khamis, R., Chong, C. K., et al. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303415 · Cited by 227 · cited 1×
“The hemodynamic environment in blood vessels is an important factor, evidenced by the fact that endothelial cells exposed to high shear stress have high cellular turnover that predisposes to replicative senescence [87,88].”
BackgroundYoung, A. R. J., & Narita, M. (2009) · The EMBO Reports · doi:10.1038/embor.2009.22 · Cited by 214
Gevaert, A. B., Shakeri, H., Leloup, A. J., Van Hove, C. E., De Meyer, G. R. Y., Vrints, C. J., Lemmens, K., & Van Craenenbroeck, E. M. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.116.003806 · Cited by 211
The Cancer SENESCopedia: A delineation of cancer cell senescence
Jochems, F., Thijssen, B., De Conti, G., Jansen, R., Pogacar, Z., Groot, K., Wang, L., Schepers, A., Wang, C., Jin, H., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109441 · Cited by 201
Han, Y., & Kim, S. Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00906-w · Cited by 201 · cited 1×
“Senescent ECs cause increased thrombosis risk and susceptibility to atherosclerosis due to increased plasminogen activator-1 (PAI-1) expression as well as reduced endothelial nitric oxide synthase (eNOS) [107].”
BackgroundVascular smooth muscle cell senescence in atherosclerosis
GORENNE, I., KAVURMA, M., SCOTT, S., & BENNETT, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.06.004 · Cited by 196 · cited 1×
“Accumulation of senescent VSMCs in atherosclerotic plaques is evidenced by reduced proliferation [114], larger and flatter cell morphology [115], increased expression of p16 INK4a and p21 CIP1/WAF1 [116], and shortened or dysfunctional telomeres [116].”
BackgroundSenescence-induced inflammation: an important player and key therapeutic target in atherosclerosis
Stojanović, S. D., Fiedler, J., Bauersachs, J., Thum, T., & Sedding, D. G. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz919 · Cited by 188
Crespo-Garcia, S., Tsuruda, P. R., Dejda, A., Ryan, R. D., Fournier, F., Chaney, S. Y., Pilon, F., Dogan, T., Cagnone, G., Patel, P., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.011 · Cited by 182
Clearance of senescent cells during cardiac ischemia–reperfusion injury improves recovery
Dookun, E., Walaszczyk, A., Redgrave, R., Palmowski, P., Tual‐Chalot, S., Suwana, A., Chapman, J., Jirkovsky, E., Donastorg Sosa, L., Gill, E., et al. (2020) · Aging Cell · doi:10.1111/acel.13249 · Cited by 173
Galactose‐modified duocarmycin prodrugs as senolytics
Guerrero, A., Guiho, R., Herranz, N., Uren, A., Withers, D. J., Martínez‐Barbera, J. P., Tietze, L. F., & Gil, J. (2020) · Aging Cell · doi:10.1111/acel.13133 · Cited by 172
Myocardial aging as a T-cell–mediated phenomenon
Ramos, G. C., van den Berg, A., Nunes-Silva, V., Weirather, J., Peters, L., Burkard, M., Friedrich, M., Pinnecker, J., Abeßer, M., Heinze, K. G., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621047114 · Cited by 168
Targeting p21Cip1 highly expressing cells in adipose tissue alleviates insulin resistance in obesity
Wang, L., Wang, B., Gasek, N. S., Zhou, Y., Cohn, R. L., Martin, D. E., Zuo, W., Flynn, W. F., Guo, C., Jellison, E. R., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.11.002 · Cited by 163
Self-citationElimination of p19ARF-expressing cells enhances pulmonary function in mice
Hashimoto, M., Asai, A., Kawagishi, H., Mikawa, R., Iwashita, Y., Kanayama, K., Sugimoto, K., Sato, T., Maruyama, M., & Sugimoto, M. (2016) · JCI Insight · doi:10.1172/jci.insight.87732 · Cited by 162 · cited 1×
“Fibrotic pulmonary diseases such as COPD and IPF have been linked to senescent cell accumulation [23,108,217,298,299].”
BackgroundYoshida, S., Nakagami, H., Hayashi, H., Ikeda, Y., Sun, J., Tenma, A., Tomioka, H., Kawano, T., Shimamura, M., Morishita, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16347-w · Cited by 161
Cellular senescence impairs the reversibility of pulmonary arterial hypertension
van der Feen, D. E., Bossers, G. P. L., Hagdorn, Q. A. J., Moonen, J.-R., Kurakula, K., Szulcek, R., Chappell, J., Vallania, F., Donato, M., Kok, K., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw4974 · Cited by 150
Wang, B., Wang, L., Gasek, N. S., Zhou, Y., Kim, T., Guo, C., Jellison, E. R., Haynes, L., Yadav, S., Tchkonia, T., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00107-6 · Cited by 145 · cited 2×
“Inactivating the NF-κB pathway in cells with high p21Cip1/Waf1 expression yielded the same results as removing the cells, and both methods attenuated insulin resistance in obese mice [11,80].”
BackgroundResultSelf-citationAMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction
Turdi, S., Fan, X., Li, J., Zhao, J., Huff, A. F., Du, M., & Ren, J. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00586.x · Cited by 141
Increased renal cellular senescence in murine high-fat diet: effect of the senolytic drug quercetin
Kim, S. R., Jiang, K., Ogrodnik, M., Chen, X., Zhu, X.-Y., Lohmeier, H., Ahmed, L., Tang, H., Tchkonia, T., Hickson, L. J., et al. (2019) · Translational Research · doi:10.1016/j.trsl.2019.07.005 · Cited by 139
Self-citationTargeted Reduction of Senescent Cell Burden Alleviates Focal Radiotherapy-Related Bone Loss
Chandra, A., Lagnado, A. B., Farr, J. N., Monroe, D. G., Park, S., Hachfeld, C., Tchkonia, T., Kirkland, J. L., Khosla, S., Passos, J. F., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3978 · Cited by 138
Self-citationPoblocka, M., Bassey, A. L., Smith, V. M., Falcicchio, M., Manso, A. S., Althubiti, M., Sheng, X., Kyle, A., Barber, R., Frigerio, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99852-2 · Cited by 137 · cited 2×
“cells through releasing duocarmycin near senescent cells [224].”
BackgroundTakeuchi, S., Takahashi, A., Motoi, N., Yoshimoto, S., Tajima, T., Yamakoshi, K., Hirao, A., Yanagi, S., Fukami, K., Ishikawa, Y., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0801 · Cited by 136
Inhibiting Cellular Senescence: A New Therapeutic Paradigm for Age-Related Osteoporosis
Khosla, S., Farr, J. N., & Kirkland, J. L. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02694 · Cited by 130
Self-citationTchkonia, T., Palmer, A. K., & Kirkland, J. L. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa728 · Cited by 129 · cited 1×
“These findings support the potential for targeting senescent cells as a therapeutic strategy to delay, prevent, alleviate, or treat multiple age-related pathologies [209].”
BackgroundSelf-citationExercise reduces circulating biomarkers of cellular senescence in humans
Englund, D. A., Sakamoto, A. E., Fritsche, C. M., Heeren, A. A., Zhang, X., Kotajarvi, B. R., Lecy, D. R., Yousefzadeh, M. J., Schafer, M. J., White, T. A., et al. (2021) · Aging Cell · doi:10.1111/acel.13415 · Cited by 125 · cited 1×
“Recent studies have proposed quantifying p16 expression of CD3-positive T cells in peripheral blood as a relatively non-invasive way to assess senescent cell burden [73,74].”
BackgroundAge- and tissue-specific expression of senescence biomarkers in mice.
Hudgins, A. D., Tazearslan, C., Tare, A., Zhu, Y., Huffman, D., & Suh, Y. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00059 · Cited by 124
Chandra, A., Lagnado, A. B., Farr, J. N., Doolittle, M., Tchkonia, T., Kirkland, J. L., LeBrasseur, N. K., Robbins, P. D., Niedernhofer, L. J., Ikeno, Y., et al. (2022) · Aging Cell · doi:10.1111/acel.13602 · Cited by 120
Self-citationTripathi, U., Misra, A., Tchkonia, T., & Kirkland, J. L. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111548 · Cited by 104
Self-citationOrally-active, clinically-translatable senolytics restore α-Klotho in mice and humans
Zhu, Y., Prata, L. G. P. L., Gerdes, E. O. W., Netto, J. M. E., Pirtskhalava, T., Giorgadze, N., Tripathi, U., Inman, C. L., Johnson, K. O., Xue, A., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103912 · Cited by 100 · cited 1×
“Post hoc analysis of the first clinical trial of senolytics revealed higher levels of the ‘geroprotective’ factor α-Klotho in urine after oral D+Q administration in each of 20 subjects with idiopathic pulmonary fibrosis [75].”
BackgroundSelf-citationBMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD/NASH
Baboota, R. K., Rawshani, A., Bonnet, L., Li, X., Yang, H., Mardinoglu, A., Tchkonia, T., Kirkland, J. L., Hoffmann, A., Dietrich, A., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00620-x · Cited by 99
Self-citationBrouilette, S. W., Whittaker, A., Stevens, S. E., van der Harst, P., Goodall, A. H., & Samani, N. J. (2008) · Heart · doi:10.1136/hrt.2007.139675 · Cited by 96 · cited 1×
“Terminal restriction fragment (TRF) analysis has indicated that the mean length of the TRF in leukocytes of coronary artery disease (CAD) patients is shorter than in controls with no family history of CAD [168].”
BackgroundTripathi, U., Nchioua, R., Prata, L. G. P. L., Zhu, Y., Gerdes, E. O. W., Giorgadze, N., Pirtskhalava, T., Parker, E., Xue, A., Espindola-Netto, J. M., et al. (2021) · Aging · doi:10.18632/aging.203560 · Cited by 88 · cited 1×
“Advanced biological age is also associated with loss of physical resilience, such as against infection [199,200], injury, or surgery or dampened vaccination responses.”
BackgroundSelf-citationmTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases
Walters, H. E., & Cox, L. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082325 · Cited by 85
Efficacy and limitations of senolysis in atherosclerosis
Garrido, A. M., Kaistha, A., Uryga, A. K., Oc, S., Foote, K., Shah, A., Finigan, A., Figg, N., Dobnikar, L., Jørgensen, H., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvab208 · Cited by 83 · cited 2×
“Senolytics such as navitoclax [162,279], anti-GPNMB vaccination [222], digoxin [217,218,280], BPTES [220], and 17-DMAG (alvespimycin) [281], reduce atherosclerotic plaque formation and inflammation in atherosclerotic model mice.”
BackgroundDasatinib plus quercetin prevents uterine age-related dysfunction and fibrosis in mice
Cavalcante, M. B., Saccon, T. D., Nunes, A. D. C., Kirkland, J. L., Tchkonia, T., Schneider, A., & Masternak, M. M. (2020) · Aging · doi:10.18632/aging.102772 · Cited by 80 · cited 1×
“Accumulating in vivo and in vitro evidence indicates that cellular senescence contributes to chronic disorders such as cardiovascular diseases [5–8], type 2 diabetes and other age-related metabolic conditions [9–17], liver disease in association with hyperinsulinemia, metabolic syndrome, age-dependent steatosis [18–20…”
BackgroundSelf-citationMicroRNA controls of cellular senescence
Suh, N. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.10.209 · Cited by 78 · cited 1×
“The microRNA (miRNA) expression and secretion profile of senescent cells has recently come into the spotlight [78,79].”
BackgroundSenescent cells suppress innate smooth muscle cell repair functions in atherosclerosis
Childs, B. G., Zhang, C., Shuja, F., Sturmlechner, I., Trewartha, S., Velasco, R. F., Baker, D. J., Li, H., & van Deursen, J. M. (2021) · Nature Aging · doi:10.1038/s43587-021-00089-5 · Cited by 76 · cited 3×
“The contractile capacity of aged VSMCs is reduced [130] due to reduced expression of proteins involved in muscle contraction, such as α-smooth muscle actin (α-SMA), smooth muscle myosin heavy chain (SM-MHC), and calponin [131,132].”
BackgroundSuvakov, S., Cubro, H., White, W. M., Butler Tobah, Y. S., Weissgerber, T. L., Jordan, K. L., Zhu, X. Y., Woollard, J. R., Chebib, F. T., Milic, N. M., et al. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0263-5 · Cited by 76 · cited 1×
“Finally, preeclampsia, a hypertensive disorder that can occur during pregnancy, has been shown to be associated with pathological senescent endothelial cell and syncytiotrophoblast accumulation [300].”
BackgroundSelf-citationHuffman, D. M., Justice, J. N., Stout, M. B., Kirkland, J. L., Barzilai, N., & Austad, S. N. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw106 · Cited by 52
Self-citationTerminally Differentiated CD4+ T Cells Promote Myocardial Inflammaging
Delgobo, M., Heinrichs, M., Hapke, N., Ashour, D., Appel, M., Srivastava, M., Heckel, T., Spyridopoulos, I., Hofmann, U., Frantz, S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.584538 · Cited by 43 · cited 1×
“It has also been speculated that senescent CD4+ T cells might infiltrate the heart and promote inflammation and an increased stress response, causing heart failure [175].”
BackgroundSanada, F., Muratsu, J., Otsu, R., Shimizu, H., Koibuchi, N., Uchida, K., Taniyama, Y., Yoshimura, S., Rakugi, H., & Morishita, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-17508-6 · Cited by 41 · cited 1×
“Other signals driving VSMC senescence are chronic exposure to high levels of the coagulation factor Xa [119,120], leading to chronic inflammation and stimulating p53 and insulin-like growth factor binding protein 5 (IGFBP-5) expression [121].”
BackgroundNath, K. A., O’Brien, D. R., Croatt, A. J., Grande, J. P., Ackerman, A. W., Nath, M. C., Yamada, S., Terzic, A., Tchkonia, T., Kirkland, J. L., et al. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00308.2018 · Cited by 40 · cited 2×
“D+Q has been shown to decrease senescent cell burden in arteriovenous fistulae allowing hemodialysis in chronic kidney disease model mice [284].”
BackgroundSelf-citationSuvakov, S., Ghamrawi, R., Cubro, H., Tu, H., White, W. M., Tobah, Y. S. B., Milic, N. M., Grande, J. P., Cunningham, J. M., Chebib, F. T., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103536 · Cited by 38 · cited 1×
“Increased senescent cell burden and high local SASP factors in the uterus have also been connected to preterm birth [301].”
BackgroundSelf-citation
Research works printed but not linked: 164
- Yu, 2021, Quercetin Reverses Cardiac Systolic Dysfunction in Mice Fed with a High-Fat Diet: Role of Angiogenesis, Oxid. Med. Cell. Longev., 2021, 8875729, 10.1155/2021/8875729 · DOI · Paper page
- Gunasekaran, 2011, Type 2 diabetes and the aging pancreatic beta cell, Aging, 3, 565, 10.18632/aging.100350 · DOI · Paper page
- Palmer, 2022, Targeting cellular senescence in metabolic disease, Mol. Metab., 66, 101601, 10.1016/j.molmet.2022.101601 · DOI
- Chaib, 2022, Obesity, Senescence, and Senolytics, Handb. Exp. Pharmacol., 274, 165, 10.1007/164_2021_555 · DOI · Paper page
- Conley, 2020, Human Obesity Induces Dysfunction and Early Senescence in Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells, Front. Cell Dev. Biol., 8, 197, 10.3389/fcell.2020.00197 · DOI · Paper page
- Escande, 2014, Deleted in Breast Cancer 1 regulates cellular senescence during obesity, Aging Cell, 13, 951, 10.1111/acel.12235 · DOI · Paper page
- Meijnikman, 2022, Hyperinsulinemia Is Highly Associated With Markers of Hepatocytic Senescence in Two Independent Cohorts, Diabetes, 71, 1929, 10.2337/db21-1076 · DOI
- Nalysnyk, 2012, Incidence and prevalence of idiopathic pulmonary fibrosis: Review of the literature, Eur. Respir. Rev., 21, 355, 10.1183/09059180.00002512 · DOI · Paper page
- Parikh, 2019, Hyperoxia-induced Cellular Senescence in Fetal Airway Smooth Muscle Cells, Am. J. Respir. Cell Mol. Biol., 61, 51, 10.1165/rcmb.2018-0176OC · DOI · Paper page
- Bian, 2019, Senescence marker activin A is increased in human diabetic kidney disease: Association with kidney function and potential implications for therapy, BMJ Open. Diabetes Res. Care, 7, e000720, 10.1136/bmjdrc-2019-000720 · DOI · Paper page
- Farr, 2019, Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans, J. Bone Miner. Res., 34, 1407, 10.1002/jbmr.3729 · DOI · Paper page
- Chirinos, J.A. (2022). Textbook of Arterial Stiffness and Pulsatile Hemodynamics in Health and Disease, Academic Press. · DOI
- Hwang, H.J., Kim, N., Herman, A.B., Gorospe, M., and Lee, J.S. (2022). Factors and Pathways Modulating Endothelial Cell Senescence in Vascular Aging. Int. J. Mol. Sci., 23. · DOI
- Yoshida, Y., Hayashi, Y., Suda, M., Tateno, K., Okada, S., Moriya, J., Yokoyama, M., Nojima, A., Yamashita, M., and Kobayashi, Y. (2014). Notch Signaling Regulates the Lifespan of Vascular Endothelial Cells via a p16-Dependent Pathway. PLoS ONE, 9. · DOI
- Kunieda, 2006, Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway, Circulation, 114, 953, 10.1161/CIRCULATIONAHA.106.626606 · DOI · Paper page
- Miyauchi, 2004, Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway, EMBO J., 23, 212, 10.1038/sj.emboj.7600045 · DOI · Paper page
- Breitschopf, 2001, Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism, FEBS Lett., 493, 21, 10.1016/S0014-5793(01)02272-4 · DOI · Paper page
- Rajendran, 2019, Autophagy and senescence: A new insight in selected human diseases, J. Cell. Physiol., 234, 21485, 10.1002/jcp.28895 · DOI · Paper page
- Bernadotte, 2016, Markers of cellular senescence. Telomere shortening as a marker of cellular senescence, Aging, 8, 3, 10.18632/aging.100871 · DOI · Paper page
- Hu, 2022, Cellular Senescence in Cardiovascular Diseases: A Systematic Review, Aging Dis., 13, 103, 10.14336/AD.2021.0927 · DOI · Paper page
- Conover, 2022, Senescence induces proteolytically-active PAPP-A secretion and association with extracellular vesicles in human pre-adipocytes, Exp. Gerontol., 172, 112070, 10.1016/j.exger.2022.112070 · DOI
- Conover, 2012, Key questions and answers about pregnancy-associated plasma protein-A, Trends Endocrinol. Metab., 23, 242, 10.1016/j.tem.2012.02.008 · DOI · Paper page
- Conover, 2015, Pregnancy-associated plasma protein-A deficiency improves survival of mice on a high fat diet, Exp. Gerontol., 70, 131, 10.1016/j.exger.2015.08.007 · doi:10.1016/j.exger.2015.08.007
- Conover, 2013, Preferential impact of pregnancy-associated plasma protein-A deficiency on visceral fat in mice on high-fat diet, Am. J. Physiol. Endocrinol. Metab., 305, E1145, 10.1152/ajpendo.00405.2013 · DOI
- Bale, 2017, Inducible knockdown of pregnancy-associated plasma protein-A gene expression in adult female mice extends life span, Aging Cell, 16, 895, 10.1111/acel.12624 · DOI
- Tanaka, 2021, Senescence-associated extracellular vesicle release plays a role in senescence-associated secretory phenotype (SASP) in age-associated diseases, J. Biochem., 169, 147, 10.1093/jb/mvaa109 · DOI
- Misawa, T., Hitomi, K., Miyata, K., Tanaka, Y., Fujii, R., Chiba, M., Loo, T.M., Hanyu, A., Kawasaki, H., and Kato, H. (2023). Identification of Novel Senescent Markers in Small Extracellular Vesicles. Int. J. Mol. Sci., 24. · DOI
- Munk, 2017, Senescence-Associated MicroRNAs, Int. Rev. Cell Mol. Biol., 334, 177, 10.1016/bs.ircmb.2017.03.008 · DOI
- Sato, 2022, CD153/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury, Journal. Clin. Investig., 132, e146071, 10.1172/JCI146071 · DOI · Paper page
- Toya, 2021, Vascular Aging Detected by Peripheral Endothelial Dysfunction Is Associated With ECG-Derived Physiological Aging, J. Am. Heart Assoc., 10, e018656, 10.1161/JAHA.120.018656 · DOI
- Kotla, 2019, Endothelial senescence is induced by phosphorylation and nuclear export of telomeric repeat binding factor 2-interacting protein, JCI Insight, 4, e124867, 10.1172/jci.insight.124867 · DOI
- Mortuza, R., Chen, S., Feng, B., Sen, S., and Chakrabarti, S. (2013). High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS ONE, 8. · DOI · Paper page
- Liu, 2020, Glucose-induced oxidative stress and accelerated aging in endothelial cells are mediated by the depletion of mitochondrial SIRTs, Physiol. Rep., 8, e14331, 10.14814/phy2.14331 · DOI · Paper page
- Clayton, 2020, Doxorubicin-Induced Oxidative Stress and Endothelial Dysfunction in Conduit Arteries Is Prevented by Mitochondrial-Specific Antioxidant Treatment, Cardio Oncol., 2, 475
- Clayton, 2021, Tumor Necrosis Factor Alpha-Mediated Inflammation and Remodeling of the Extracellular Matrix Underlies Aortic Stiffening Induced by the Common Chemotherapeutic Agent Doxorubicin, Hypertension, 77, 1581, 10.1161/HYPERTENSIONAHA.120.16759 · DOI
- Dagher, 2021, Design of a Randomized Placebo-Controlled Trial to Evaluate the Anti-inflammatory and Senolytic Effects of Quercetin in Patients Undergoing Coronary Artery Bypass Graft Surgery, Front. Cardiovasc. Med., 8, 741542, 10.3389/fcvm.2021.741542 · DOI
- Vasa, 2000, Nitric oxide activates telomerase and delays endothelial cell senescence, Circ. Res., 87, 540, 10.1161/01.RES.87.7.540 · DOI · Paper page
- Yokoyama, 2019, p53 plays a crucial role in endothelial dysfunction associated with hyperglycemia and ischemia, J. Mol. Cell. Cardiol., 129, 105, 10.1016/j.yjmcc.2019.02.010 · DOI
- Yokoyama, 2014, Inhibition of endothelial p53 improves metabolic abnormalities related to dietary obesity, Cell Rep., 7, 1691, 10.1016/j.celrep.2014.04.046 · DOI · Paper page
- Hayashi, 2006, Endothelial cellular senescence is inhibited by nitric oxide: Implications in atherosclerosis associated with menopause and diabetes, Proc. Natl. Acad. Sci. USA, 103, 17018, 10.1073/pnas.0607873103 · DOI · Paper page
- Bloom, 2023, Mechanisms and consequences of endothelial cell senescence, Nat. Rev. Cardiol., 20, 38, 10.1038/s41569-022-00739-0 · DOI · Paper page
- Donato, 2009, Vascular endothelial dysfunction with aging: Endothelin-1 and endothelial nitric oxide synthase, Am. J. Physiol.-Heart Circ. Physiol., 297, H425, 10.1152/ajpheart.00689.2008 · DOI · Paper page
- 2001, The endothelium as a metabolic and endocrine organ: Its relation with insulin resistance, Exp. Clin. Endocrinol. Diabetes, 109, S166, 10.1055/s-2001-18579 · doi:10.1055/s-2001-18579
- Garfinkel, 1994, Post-transcriptional regulation of interleukin 1 alpha in various strains of young and senescent human umbilical vein endothelial cells, Proc. Natl. Acad. Sci. USA, 91, 1559, 10.1073/pnas.91.4.1559 · DOI · Paper page
- Matacchione, 2021, Anti-SASP and anti-inflammatory activity of resveratrol, curcumin and β-caryophyllene association on human endothelial and monocytic cells, Biogerontology, 22, 297, 10.1007/s10522-021-09915-0 · DOI
- Culley, 2021, Frataxin deficiency promotes endothelial senescence in pulmonary hypertension, J. Clin. Investig., 131, e136459, 10.1172/JCI136459 · DOI
- Chang, 2013, Telomerase- and angiogenesis-related gene responses to irradiation in human umbilical vein endothelial cells, Int. J. Mol. Med., 31, 1202, 10.3892/ijmm.2013.1300 · DOI
- Suda, M., Shimizu, I., Yoshida, Y., Hayashi, Y., Ikegami, R., Katsuumi, G., Wakasugi, T., Yoshida, Y., Okuda, S., and Soga, T. (2017). Inhibition of dipeptidyl peptidase-4 ameliorates cardiac ischemia and systolic dysfunction by up-regulating the FGF-2/EGR-1 pathway. PLoS ONE, 12. · DOI
- Sano, 2007, p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload, Nature, 446, 444, 10.1038/nature05602 · DOI · Paper page
- Chi, 2019, Vascular smooth muscle cell senescence and age-related diseases: State of the art, Biochim. Biophys. Acta Mol. Basis Dis., 1865, 1810, 10.1016/j.bbadis.2018.08.015 · DOI · Paper page
- Bennett, 1998, Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques, Circ. Res., 82, 704, 10.1161/01.RES.82.6.704 · DOI · Paper page
- Yu, 2016, The role of mitochondrial DNA damage in the development of atherosclerosis, Free. Radic. Biol. Med., 100, 223, 10.1016/j.freeradbiomed.2016.06.011 · DOI
- Canugovi, 2019, Increased mitochondrial NADPH oxidase 4 (NOX4) expression in aging is a causative factor in aortic stiffening, Redox Biol., 26, 101288, 10.1016/j.redox.2019.101288 · DOI
- Otuki, 2018, Effects of Direct Oral Anticoagulants at the Peak Phase, Trough Phase, and After Vascular Injury, J. Am. Coll. Cardiol., 71, 102, 10.1016/j.jacc.2017.10.076 · doi:10.1016/j.jacc.2017.10.076
- Hayashi, 2022, Coagulation factors promote brown adipose tissue dysfunction and abnormal systemic metabolism in obesity, iScience, 25, 104547, 10.1016/j.isci.2022.104547 · DOI
- Bennett, 2016, Basic research: Killing the old: Cell senescence in atherosclerosis, Nat. Rev. Cardiol., 14, 8, 10.1038/nrcardio.2016.195 · DOI
- Furuuchi, 2022, Endothelial SIRT-1 has a critical role in the maintenance of capillarization in brown adipose tissue, iScience, 25, 105424, 10.1016/j.isci.2022.105424 · DOI
- Grootaert, 2021, SIRT6 Protects Smooth Muscle Cells From Senescence and Reduces Atherosclerosis, Circ. Res., 128, 474, 10.1161/CIRCRESAHA.120.318353 · DOI · Paper page
- Gardner, 2015, Senescent Vascular Smooth Muscle Cells Drive Inflammation Through an Interleukin-1α-Dependent Senescence-Associated Secretory Phenotype, Arterioscler. Thromb. Vasc. Biol., 35, 1963, 10.1161/ATVBAHA.115.305896 · DOI · Paper page
- Soto, 2014, Aging in blood vessels. Medicinal agents FOR systemic arterial hypertension in the elderly, Ageing Res. Rev., 18, 132, 10.1016/j.arr.2014.10.001 · DOI
- Lacolley, 2017, Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease, Physiol. Rev., 97, 1555, 10.1152/physrev.00003.2017 · DOI · Paper page
- Lacolley, 2018, Smooth muscle cell and arterial aging: Basic and clinical aspects, Cardiovasc. Res., 114, 513, 10.1093/cvr/cvy009 · DOI · Paper page
- Schurgers, 2018, Initiation and Propagation of Vascular Calcification Is Regulated by a Concert of Platelet- and Smooth Muscle Cell-Derived Extracellular Vesicles, Front. Cardiovasc. Med., 5, 36, 10.3389/fcvm.2018.00036 · DOI
- Ikeda, 2009, Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition, Am. J. Physiol. Heart Circ. Physiol., 297, H1673, 10.1152/ajpheart.00455.2009 · DOI · Paper page
- Huang, 2020, Carnosine attenuates vascular smooth muscle cells calcification through mTOR signaling pathway, Aging Med., 3, 153, 10.1002/agm2.12125 · DOI
- Wakasugi, T., Shimizu, I., Yoshida, Y., Hayashi, Y., Ikegami, R., Suda, M., Katsuumi, G., Nakao, M., Hoyano, M., and Kashimura, T. (2019). Role of smooth muscle cell p53 in pulmonary arterial hypertension. PLoS ONE, 14. · DOI
- Ball, 2005, Telomere-independent cellular senescence in human fetal cardiomyocytes, Aging Cell, 4, 21, 10.1111/j.1474-9728.2004.00137.x · DOI
- Mitry, 2020, Accelerated cardiomyocyte senescence contributes to late-onset doxorubicin-induced cardiotoxicity, Am. J. Physiol. Cell Physiol., 318, C380, 10.1152/ajpcell.00073.2019 · DOI
- Zhang, 2007, Hypoxia reoxygenation induces premature senescence in neonatal SD rat cardiomyocytes, Acta Pharmacol. Sin., 28, 44, 10.1111/j.1745-7254.2007.00488.x · DOI
- Nomura, 2018, Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure, Nat. Commun., 9, 4435, 10.1038/s41467-018-06639-7 · DOI · Paper page
- Spallarossa, 2009, Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2, Am. J. Physiol. Heart Circ. Physiol., 297, H2169, 10.1152/ajpheart.00068.2009 · DOI · Paper page
- Maejima, 2008, Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage, Aging Cell, 7, 125, 10.1111/j.1474-9726.2007.00358.x · DOI · Paper page
- Massion, 2003, Nitric Oxide and Cardiac Function, Circ. Res., 93, 388, 10.1161/01.RES.0000088351.58510.21 · DOI · Paper page
- Shimizu, 2012, p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure, Cell Metab., 15, 51, 10.1016/j.cmet.2011.12.006 · DOI · Paper page
- Tang, 2020, Cardiomyocyte Senescence and Cellular Communications Within Myocardial Microenvironments, Front. Endocrinol., 11, 280, 10.3389/fendo.2020.00280 · DOI · Paper page
- Cui, 2018, Postinfarction Hearts Are Protected by Premature Senescent Cardiomyocytes Via GATA 4-Dependent CCN 1 Secretion, J. Am. Heart Assoc., 7, e009111, 10.1161/JAHA.118.009111 · DOI · Paper page
- Zhang, 2019, Trimetazidine and l-carnitine prevent heart aging and cardiac metabolic impairment in rats via regulating cardiac metabolic substrates, Exp. Gerontol., 119, 120, 10.1016/j.exger.2018.12.019 · DOI
- Dillon, 2012, The role of PGC-1 coactivators in aging skeletal muscle and heart, IUBMB Life, 64, 231, 10.1002/iub.608 · DOI · Paper page
- Mailleux, 2018, AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation, Nat. Commun., 9, 374, 10.1038/s41467-017-02795-4 · DOI · Paper page
- Tang, 2017, SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy, Circulation, 136, 2051, 10.1161/CIRCULATIONAHA.117.028728 · DOI · Paper page
- Kane, 2018, Sirtuins and NAD(+) in the Development and Treatment of Metabolic and Cardiovascular Diseases, Circ. Res., 123, 868, 10.1161/CIRCRESAHA.118.312498 · DOI · Paper page
- Burke, 1997, Coronary risk factors and plaque morphology in men with coronary disease who died suddenly, N. Engl. J. Med., 336, 1276, 10.1056/NEJM199705013361802 · DOI · Paper page
- Libby, 2008, Diversity of Denizens of the Atherosclerotic Plaque, Circulation, 117, 3168, 10.1161/CIRCULATIONAHA.108.783068 · DOI · Paper page
- Newby, 2009, Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes, Thromb. Haemost., 101, 1006, 10.1160/TH08-07-0469 · DOI · Paper page
- Johnson, 2006, Vascular calcification: Pathobiological mechanisms and clinical implications, Circ. Res., 99, 1044, 10.1161/01.RES.0000249379.55535.21 · DOI · Paper page
- Allahverdian, 2018, Smooth muscle cell fate and plasticity in atherosclerosis, Cardiovasc. Res., 114, 540, 10.1093/cvr/cvy022 · DOI · Paper page
- Childs, 2016, Senescent intimal foam cells are deleterious at all stages of atherosclerosis, Science, 354, 472, 10.1126/science.aaf6659 · DOI · Paper page
- Richardson, 2018, Telomerase Mediates Lymphocyte Proliferation but Not the Atherosclerosis-Suppressive Potential of Regulatory T-Cells, Arterioscler. Thromb. Vasc. Biol., 38, 1283, 10.1161/ATVBAHA.117.309940 · DOI
- Bernal, 2019, T cell senescence predicts subclinical atherosclerosis in HIV-infected patients similarly to traditional cardiovascular risk factors, Antiviral Res., 162, 163, 10.1016/j.antiviral.2018.12.014 · DOI
- Yu, 2016, T cell senescence and cardiovascular diseases, Clin. Exp. Med., 16, 257, 10.1007/s10238-015-0376-z · DOI · Paper page
- Varricchi, 2020, The emerging role of T follicular helper (T(FH)) cells in aging: Influence on the immune frailty, Ageing Res. Rev., 61, 101071, 10.1016/j.arr.2020.101071 · DOI
- Bazioti, 2022, T cell cholesterol efflux suppresses apoptosis and senescence and increases atherosclerosis in middle aged mice, Nat. Commun., 13, 3799, 10.1038/s41467-022-31135-4 · DOI · Paper page
- Youn, 2013, Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension, Hypertension, 62, 126, 10.1161/HYPERTENSIONAHA.113.00689 · DOI · Paper page
- Youn, 2015, Characterization of CD8(+)CD57(+) T cells in patients with acute myocardial infarction, Cell. Mol. Immunol., 12, 466, 10.1038/cmi.2014.74 · DOI
- Kaplan, 2011, T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women, J. Infect. Dis., 203, 452, 10.1093/infdis/jiq071 · DOI · Paper page
- Liuzzo, 2007, Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events, J. Am. Coll. Cardiol., 50, 1450, 10.1016/j.jacc.2007.06.040 · DOI · Paper page
- Asahara, 1997, Isolation of putative progenitor endothelial cells for angiogenesis, Science, 275, 964, 10.1126/science.275.5302.964 · DOI · Paper page
- Takahashi, 1999, Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization, Nat. Med., 5, 434, 10.1038/7434 · DOI · Paper page
- Werner, 2006, Clinical and therapeutical implications of EPC biology in atherosclerosis, J. Cell. Mol. Med., 10, 318, 10.1111/j.1582-4934.2006.tb00402.x · DOI
- Vasa, 2001, Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease, Circ. Res., 89, E1, 10.1161/hh1301.093953 · DOI · Paper page
- Yang, 1999, Human endothelial cell life extension by telomerase expression, J. Biol. Chem., 274, 26141, 10.1074/jbc.274.37.26141 · DOI · Paper page
- Torella, 2004, Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression, Circ. Res., 94, 514, 10.1161/01.RES.0000117306.10142.50 · DOI · Paper page
- Cesselli, 2011, Effects of age and heart failure on human cardiac stem cell function, Am. J. Pathol., 179, 349, 10.1016/j.ajpath.2011.03.036 · DOI · Paper page
- Castaldi, 2017, Decline in cellular function of aged mouse c-kit(+) cardiac progenitor cells, J. Physiol., 595, 6249, 10.1113/JP274775 · DOI
- Marino, 2022, Diabetes-Induced Cellular Senescence and Senescence-Associated Secretory Phenotype Impair Cardiac Regeneration and Function Independently of Age, Diabetes, 71, 1081, 10.2337/db21-0536 · DOI
- Zhu, F., Li, Y., Zhang, J., Piao, C., Liu, T., Li, H.H., and Du, J. (2013). Senescent cardiac fibroblast is critical for cardiac fibrosis after myocardial infarction. PLoS ONE, 8. · DOI · Paper page
- Jia, 2017, Haplodeficiency of Ataxia Telangiectasia Mutated Accelerates Heart Failure After Myocardial Infarction, J. Am. Heart Assoc., 6, e006349, 10.1161/JAHA.117.006349 · DOI · Paper page
- Li, K., Li, Y., Yu, Y., Ding, J., Huang, H., Chu, C., Hu, L., Yu, Y., Cao, Y., and Xu, P. (2021). Bmi-1 alleviates adventitial fibroblast senescence by eliminating ROS in pulmonary hypertension. BMC Pulm. Med., 21. · DOI
- Roger, I., Milara, J., Belhadj, N., and Cortijo, J. (2021). Senescence Alterations in Pulmonary Hypertension. Cells, 10. · DOI
- Sawaki, 2018, Visceral Adipose Tissue Drives Cardiac Aging Through Modulation of Fibroblast Senescence by Osteopontin Production, Circulation, 138, 809, 10.1161/CIRCULATIONAHA.117.031358 · DOI · Paper page
- Kamo, 2015, Cardiac nonmyocytes in the hub of cardiac hypertrophy, Circ. Res., 117, 89, 10.1161/CIRCRESAHA.117.305349 · DOI · Paper page
- Kakkar, 2010, Intramyocardial fibroblast myocyte communication, Circ. Res., 106, 47, 10.1161/CIRCRESAHA.109.207456 · DOI · Paper page
- Civitarese, 2017, Role of integrins in mediating cardiac fibroblast-cardiomyocyte cross talk: A dynamic relationship in cardiac biology and pathophysiology, Basic. Res. Cardiol., 112, 6, 10.1007/s00395-016-0598-6 · DOI
- Shibamoto, 2019, Activation of DNA Damage Response and Cellular Senescence in Cardiac Fibroblasts Limit Cardiac Fibrosis After Myocardial Infarction, Int. Heart J., 60, 944, 10.1536/ihj.18-701 · DOI
- Xie, 2015, Mitochondrial oxidative stress promotes atrial fibrillation, Sci. Rep., 5, 11427, 10.1038/srep11427 · DOI · Paper page
- Chang, 2008, Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer, Br. J. Cancer, 99, 1074, 10.1038/sj.bjc.6604676 · DOI · Paper page
- Xi, 2012, Eph receptors and ephrins as targets for cancer therapy, J. Cell. Mol. Med., 16, 2894, 10.1111/j.1582-4934.2012.01612.x · DOI · Paper page
- Johmura, 2021, Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders, Science, 371, 265, 10.1126/science.abb5916 · DOI · Paper page
- Suda, 2022, Glycoprotein nonmetastatic melanoma protein B regulates lysosomal integrity and lifespan of senescent cells, Sci. Rep., 12, 6522, 10.1038/s41598-022-10522-3 · DOI · Paper page
- Minamino, 2009, A crucial role for adipose tissue p53 in the regulation of insulin resistance, Nat. Med., 15, 1082, 10.1038/nm.2014 · DOI · Paper page
- Flores, 2001, Tumor susceptibility of p21(Waf1/Cip1)-deficient mice, Cancer Res., 61, 6234
- Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
- Zhang, 2011, A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects, Cell Stem Cell, 8, 31, 10.1016/j.stem.2010.12.002 · DOI · Paper page
- UK Prospective Diabetes Study (UKPDS) Group (1998). Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet, 352, 854–865. · DOI · Paper page
- Wang, 2010, Rad as a novel regulator of excitation-contraction coupling and beta-adrenergic signaling in heart, Circ. Res., 106, 317, 10.1161/CIRCRESAHA.109.208272 · DOI · Paper page
- Hurez, 2015, Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice, Aging Cell, 14, 945, 10.1111/acel.12380 · DOI · Paper page
- Verstovsek, 2010, Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis, N. Engl. J. Med., 363, 1117, 10.1056/NEJMoa1002028 · DOI · Paper page
- Sunderland, 2023, Senolytics rejuvenate the reparative activity of human cardiomyocytes and endothelial cells, J. Cardiovasc. Aging, 3, 21
- Panchal, 2012, Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats, J. Nutr., 142, 1026, 10.3945/jn.111.157263 · DOI · Paper page
- Alfonso, 2022, Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice, Pharmacol. Res., 183, 106356, 10.1016/j.phrs.2022.106356 · DOI
- Iske, 2020, Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation, Nat. Commun., 11, 4289, 10.1038/s41467-020-18039-x · DOI · Paper page
- Jia, 2020, Senolytic Agent Navitoclax Inhibits Angiotensin II-Induced Heart Failure in Mice, J. Cardiovasc. Pharmacol., 76, 452, 10.1097/FJC.0000000000000878 · DOI · Paper page
- Xintarakou, 2020, Atrial fibrosis as a dominant factor for the development of atrial fibrillation: Facts and gaps, Europace, 22, 342, 10.1093/europace/euaa009 · DOI
- Adili, 2022, Atrial Fibrillation Underlies Cardiomyocyte Senescence and Contributes to Deleterious Atrial Remodeling during Disease Progression, Aging Dis., 13, 298, 10.14336/AD.2021.0619 · DOI
- Jesel, L., Abbas, M., Park, S.H., Matsushita, K., Kindo, M., Hasan, H., Auger, C., Sato, C., Ohlmann, P., and Mazzucotelli, J.P. (2019). Atrial Fibrillation Progression Is Associated with Cell Senescence Burden as Determined by p53 and p16 Expression. J. Clin. Med., 9. · DOI
- Wang, 2021, Quercetin improves atrial fibrillation through inhibiting TGF-β/Smads pathway via promoting MiR-135b expression, Phytomedicine, 93, 153774, 10.1016/j.phymed.2021.153774 · DOI
- Liu, 2019, Fisetin Alleviates Atrial Inflammation, Remodeling, and Vulnerability to Atrial Fibrillation after Myocardial Infarction, Int. Heart J., 60, 1398, 10.1536/ihj.19-131 · DOI
- Xie, 2017, Premature senescence of cardiac fibroblasts and atrial fibrosis in patients with atrial fibrillation, Oncotarget, 8, 57981, 10.18632/oncotarget.19853 · DOI · Paper page
- Lee, 2021, Local delivery of a senolytic drug in ischemia and reperfusion-injured heart attenuates cardiac remodeling and restores impaired cardiac function, Acta Biomater., 135, 520, 10.1016/j.actbio.2021.08.028 · DOI
- Salerno, 2022, Pharmacological clearance of senescent cells improves cardiac remodeling and function after myocardial infarction in female aged mice, Mech. Ageing Dev., 208, 111740, 10.1016/j.mad.2022.111740 · DOI
- Makkar, 2012, Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial, Lancet, 379, 895, 10.1016/S0140-6736(12)60195-0 · DOI · Paper page
- Hare, 2017, Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial, J. Am. Coll. Cardiol., 69, 526, 10.1016/j.jacc.2016.11.009 · DOI · Paper page
- Alexandre, 2020, Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines, J. Am. Heart Assoc., 9, e018403, 10.1161/JAHA.120.018403 · DOI · Paper page
- Zamorano, 2016, 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC), Eur. Heart J., 37, 2768, 10.1093/eurheartj/ehw211 · DOI · Paper page
- Bulten, 2019, Cardiac molecular pathways influenced by doxorubicin treatment in mice, Sci. Rep., 9, 2514, 10.1038/s41598-019-38986-w · doi:10.1038/s41598-019-38986-w
- Shi, 2016, Digoxin reduces atherosclerosis in apolipoprotein E-deficient mice, Br. J. Pharmacol., 173, 1517, 10.1111/bph.13453 · DOI · Paper page
- Lazaro, 2015, Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice, Diabetes, 64, 3600, 10.2337/db14-1926 · DOI · Paper page
- Kim, 2022, A Senolytic-Eluting Coronary Stent for the Prevention of In-Stent Restenosis, ACS Biomater. Sci. Eng., 8, 1921, 10.1021/acsbiomaterials.1c01611 · DOI
- Parvizi, 2021, Senolytic agents lessen the severity of abdominal aortic aneurysm in aged mice, Exp. Gerontol., 151, 111416, 10.1016/j.exger.2021.111416 · DOI
- Tateno, 2008, Cell therapy for cardiovascular diseases, Ann. Vasc. Dis., 1, 66, 10.3400/avd.AVDsr00108 · doi:10.3400/avd.avdsr00108
- Oda, 2010, Establishment of culturing system for ex-vivo expansion of angiogenic immature erythroid cells, and its application for treatment of patients with chronic severe lower limb ischemia, J. Mol. Cell. Cardiol., 49, 347, 10.1016/j.yjmcc.2010.04.001 · DOI
- Tateno, 2006, Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization, Circ. Res., 98, 1194, 10.1161/01.RES.0000219901.13974.15 · DOI · Paper page
- Forman, 2021, Cardiovascular care of older adults, Bmj, 374, n1593
- Young, 2002, Blood pressure and decline in kidney function: Findings from the Systolic Hypertension in the Elderly Program (SHEP), J. Am. Soc. Nephrol., 13, 2776, 10.1097/01.ASN.0000031805.09178.37 · DOI · Paper page
- Izzo, 2000, Clinical Advisory Statement. Importance of systolic blood pressure in older Americans, Hypertension, 35, 1021, 10.1161/01.HYP.35.5.1021 · DOI · Paper page
- Higashi, 2012, Endothelial dysfunction and hypertension in aging, Hypertens. Res., 35, 1039, 10.1038/hr.2012.138 · DOI · Paper page
- Kawaguchi, 2021, Cellular senescence promotes cancer metastasis by enhancing soluble E-cadherin production, iScience, 24, 103022, 10.1016/j.isci.2021.103022 · DOI
- Asaithamby, 2022, Cellular senescence and lung cancer prognosis, Transl. Lung Cancer Res., 11, 1982, 10.21037/tlcr-22-678 · DOI
- Mikawa, 2018, Elimination of p19(ARF) -expressing cells protects against pulmonary emphysema in mice, Aging Cell, 17, e12827, 10.1111/acel.12827 · DOI · Paper page
- Wyles, 2023, A chronic wound model to investigate skin cellular senescence, Aging, 15, 2852
- Dańczak-Pazdrowska, A., Gornowicz-Porowska, J., Polańska, A., Krajka-Kuźniak, V., Stawny, M., Gostyńska, A., Rubiś, B., Nourredine, S., Ashiqueali, S., and Schneider, A. (2023). Cellular senescence in skin-related research: Targeted signaling pathways and naturally occurring therapeutic agents. Aging Cell, e13845. · DOI
- Kirkland, 2023, Tumor dormancy and disease recurrence, Cancer Metastasis Rev., 42, 9, 10.1007/s10555-023-10096-0 · DOI
- Rahman, 2022, Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition, Mol. Cancer Res., 20, 938, 10.1158/1541-7786.MCR-21-0029 · DOI
- Prasanna, 2021, Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy, J. Natl. Cancer Inst., 113, 1285, 10.1093/jnci/djab064 · DOI · Paper page
Cited by
The senescence-associated secretory phenotype and its physiological and pathological implications
Wang, B., Han, J., Elisseeff, J. H., & Demaria, M. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00727-x · Cited by 948
Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype
Maus, M., López-Polo, V., Mateo, L., Lafarga, M., Aguilera, M., De Lama, E., Meyer, K., Sola, A., Lopez-Martinez, C., López-Alonso, I., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00928-2 · Cited by 215
Rejuvenation Strategy for Inducing and Enhancing Autoimmune Response to Eliminate Senescent Cells
Wang, X., Zhang, C., Su, J., Ren, S., Wang, X., Zhang, Y., Yuan, Z., He, X., Wu, X., Li, M., et al. (2025) · Aging and disease · doi:10.14336/ad.2024.0579 · Cited by 8
Bertoli, G., Phadke, K., Cospito, A., Rizk, J. A., Zhang, M., Miliotou, E., Cammer, M., Deng, Y., Mezzano, V., Alu, M., et al. (2025) · doi:10.1101/2025.10.22.682160 · Cited by 2
(2026) · doi:10.1161/jaha.125.047447 · Cited by 2
Metadata
- Authors
- Suda, M., Paul, K. H., Minamino, T., Miller, J. D., Lerman, A., Ellison-Hughes, G. M., Tchkonia, T., & Kirkland, J. L.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2023-05-02
- Volume
- 12
- Issue
- 9
- Pages
- 1296
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W4368405370
- Cited by
- 112
- References
- 138
- FWCI
- 16.22
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- US National Institutes of Health (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
- a Grant-in-Aid for Scientific Research (A) (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
- Grant-in-Aid for Challenging Research (Pioneering) (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
- MEXT, AMED-CREST (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
- the Moonshot Research and Development Program (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
- Heart Research (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
- King’s Together Fund Strategic Award, and ‘RENOIR’, the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.